$ABT

$103.36 -$1.53 (1.45%) Live

$ABT Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Company Executives

$ABT Management Team

Mr. Randel Woodgrift

Senior Vice President - Cardio Rhythm Management

Age 62

Compensation -

Sex Male

Mr. Robert Ford

Chairman of the Board

Chief Executive Officer

Age 51

Compensation $22.78M USD

Sex Male

Mr. Philip Boudreau

Chief Financial Officer

Executive Vice President - Finance

Age 52

Compensation $8.226M USD

Sex Male

Mr. Hubert Allen

Executive Vice President

General Counsel

Secretary

Age 59

Compensation $7.981M USD

Sex Male

Ms. Mary Moreland

Executive Vice President - Human Resources

Age 58

Compensation -

Sex Female

Ms. Lisa Earnhardt

Executive Vice President

Group President - Medical Devices

Age 55

Compensation $6.558M USD

Sex Female

Mr. Louis Morrone

Executive Vice President - Core Diagnostics

Age 48

Compensation -

Sex Male

Mr. Daniel Salvadori

Executive Vice President

Group President - Established Pharmaceuticals and Nutritional Products

Age 46

Compensation $5.790M USD

Sex Male

Ms. Andrea Wainer

Executive Vice President - Rapid and Molecular Diagnostics

Age 56

Compensation $6.287M USD

Sex Female

Mr. John Mccoy

Vice President - Finance

Controller

Age 55

Compensation -

Sex Male

Name / Title	Age	Compensation	Sex
Mr. Randel Woodgrift Senior Vice President - Cardio Rhythm Management	62	-	Male
Mr. Robert Ford Chairman of the Board Chief Executive Officer	51	$22.78M USD	Male
Mr. Philip Boudreau Chief Financial Officer Executive Vice President - Finance	52	$8.226M USD	Male
Mr. Hubert Allen Executive Vice President General Counsel Secretary	59	$7.981M USD	Male
Ms. Mary Moreland Executive Vice President - Human Resources	58	-	Female
Ms. Lisa Earnhardt Executive Vice President Group President - Medical Devices	55	$6.558M USD	Female
Mr. Louis Morrone Executive Vice President - Core Diagnostics	48	-	Male
Mr. Daniel Salvadori Executive Vice President Group President - Established Pharmaceuticals and Nutritional Products	46	$5.790M USD	Male
Ms. Andrea Wainer Executive Vice President - Rapid and Molecular Diagnostics	56	$6.287M USD	Female
Mr. John Mccoy Vice President - Finance Controller	55	-	Male

Board of Directors

From the proxy statement filed Mar 13, 2026

Directors

serving now

Independent

12 of 13

stated in the proxy

Average tenure

7.3 years

from year joined

CEO also chairs the board

Yes

Robert B. Ford

Director	Age	On board	Independent	Committees	Other public boards	Pay
Nita Ahuja, M.D.	59	2025 1 year	Independent	None stated	None stated	Not stated
Claire Babineaux-Fontenot	61	2022 4 years	Independent	None stated	None stated	Not stated
Sally E. Blount, Ph.D.	64	2011 15 years	Independent	None stated	None stated	Not stated
Robert B. Ford Board chair, CEO	52	2019 7 years	Not independent	•Executive · Chair	None stated	Paid as CEO
Paola Gonzalez	54	2021 5 years	Independent	•Audit •Nominations and Governance	None stated	Not stated
Michelle A. Kumbier	58	2018 8 years	Independent	•Audit •Compensation	Teledyne Technologies Incorporated, Ryerson Holding Corporation	Not stated
Darren W. McDew	65	2019 7 years	Independent	None stated	Parsons Corporation, GE Aerospace	Not stated
Nancy McKinstry Lead independent director	67	2011 15 years	Independent	•Audit · Chair •Compensation •Executive	Accenture plc, Mondelēz International, Inc.	Not stated
Michael G. O’Grady	60	2023 3 years	Independent	•Compensation •Nominations and Governance	Northern Trust Corporation	Not stated
Michael F. Roman	66	2021 5 years	Independent	None stated	Waystar Holding Corp.	Not stated
Daniel J. Starks	71	2017 9 years	Independent	None stated	None stated	Not stated
John G. Stratton	65	2017 9 years	Independent	•Audit •Nominations and Governance · Chair •Executive	General Dynamics Corporation	Not stated
Robert J. Alpern, M.D. Leaving at the meeting	Not stated	Not stated	Independent	None stated	None stated	Not stated

Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive.

1 disclosed in the proxy filed Mar 13, 2026

Son-in-law of Sally E. Blount, Ph.D.

son-in-law of one of Abbott’s directors, Sally E. Blount, Ph.D.

Amount not stated

2025

Employment of a director's son-in-law by Abbott, with total compensation exceeding the policy review threshold.

With Abbott Open in proxy

Comments

Company Executives

$ABT Management Team

Mr. Randel Woodgrift

Mr. Robert Ford

Mr. Philip Boudreau

Mr. Hubert Allen

Ms. Mary Moreland

Ms. Lisa Earnhardt

Mr. Louis Morrone

Mr. Daniel Salvadori

Ms. Andrea Wainer

Mr. John Mccoy

Board of Directors

Related-party transactions